BackBrickell Biotech Overview

Brickell Biotech Net Tangible Assets

Brickell Biotech's net tangible assets is $16M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$15.64M
30.05% YoYΔ $-6.72M vs prior year quarter

Peer average

Loading

Brickell Biotech Net Tangible Assets History

Loading

Brickell Biotech vs. peers: Net Tangible Assets Comparison

Loading

Brickell Biotech Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Brickell Biotech (BBI) FAQ

As of the most recent data (June 2022), BBI shows a net tangible assets of $16M. That compares with $22M in the prior-year period — down 30.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBI's net tangible assets is now $16M (was $22M) — a 30.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Brickell Biotech is outperforming or lagging.

Tracking BBI's net tangible assets over time shows whether Brickell Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $22M in the prior-year period — down 30.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Brickell Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $16M) with ownership activity and broader fundamentals.

Brickell Biotech's net tangible assets is $16M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.